CHI3L1 monoclonal antibody therapy mitigates cognitive impairment by inhibiting neuroinflammation through ERK and NF-κB pathway in Tg2576 mice.

Although the reduction in TNF-α expression did not reach statistical significance, a decreasing trend was evident, suggesting that an increased number of experimental replicates may reveal a statistically significant effect.

also in 47,180 other papers